Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.3 EUR | -0.42% | +12.95% | +98.61% |
Apr. 17 | Medincell: share price rises following agreement with AbbVie | CF |
Apr. 16 | Medincell, AbbVie to Co-Develop Injectable Therapeutics | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+98.61% | 443M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- MEDCL Stock
- News MedinCell S.A.
- MedinCell S A : Study Finds Oral Form of Antiparasitic Ivermectin Safe